Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Stacey GandlerBrand Nourishment
-- OV101 in Angelman syndrome: Pivotal Phase 3 NEPTUNE trial expected to begin in ...
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email